GAP
(Gemcitabine Abraxane Pancreas) trial
A PHASE II RANDOMIZED TRIAL COMPARING A COMBINATION OF ABRAXANE AND GEMCITABINE VERSUS GEMCITABINE ALONE AS FIRST LINE TREATMENT IN LOCALLY ADVANCED UNRESECTABLE PANCREATIC CANCER
· INVESTIGATOR MEETING - Novembre 2018
Scarica il file
· NEWSLETTER
Scarica il file
· SINOSSI
Scarica il file
· INVESTIGATOR MEETING - Gennaio 2018
Scarica il file